CP1
Click for more information
0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Quarterly Report 30 June 2019, page-12

  1. StockObserver
    1,303 Posts.
    lightbulb Created with Sketch. 580
    clock Created with Sketch.
    16/09/19
    22:16
    Post #: 40443756
    There should be quite a bit of news to follow over next few months. FDA (INAD) application, CSRIO collaboration, CPAT-01 trial update/result read out, DermaCann trial and possible distribution agreements.

    I suspect things could heat up for CP1 in the coming months.

    All IMO. DYOR
    CP1 Price at posting: 16.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
NEWS Bitcoin investors need to know the risks
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.